Journal profile · Peripheral Vascular Disease
Atherosclerosis
ISSN 0021-9150 · eISSN 1879-1484 · Elsevier Ireland Ltd · UNITED STATES · Monthly · Founded 1970
Atherosclerosis: CAS Zone 2 · Medicine (2025 upgraded edition, Top journal); impact factor 6.93; hybrid open access; APC about USD 4,020; median 105 days to acceptance (98 articles, last 24 months); 906 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Atherosclerosis is published by Elsevier Ireland Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins and Atherosclerosis and Cardiovascular Diseases, together about 34.8% of its articles. Its main subfields are Cardiology and Cardiovascular Medicine. (generated from OpenAlex topic counts and CAS ranking data)
Browse through a wide range of high-quality academic journals offered by Elsevier, including open access options, to enrich your research journey.
From the journal's Aims & Scope
Research area (LetPub): Peripheral Vascular Disease
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lipoproteins and Cardiovascular HealthMedicine17.1%
- Diabetes, Cardiovascular Risks, and LipoproteinsMedicine10%
- Atherosclerosis and Cardiovascular DiseasesImmunology and Microbiology7.7%
- Cancer, Lipids, and MetabolismBiochemistry, Genetics and Molecular Biology7%
- Adipokines, Inflammation, and Metabolic DiseasesMedicine5.6%
- Cardiovascular Disease and AdiposityMedicine5.4%
- Cholesterol and Lipid MetabolismMedicine5.2%
- Cardiovascular Health and Disease PreventionMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Peripheral Vascular Disease | Zone 2 |
| Minor | Cardiac & Cardiovascular Systems | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.93LetPub ·
- CiteScore 2026-06
- 10.2LetPub ·
- SJR 2026-06
- 2.18LetPub ·
- SNIP 2026-06
- 1.62LetPub ·
- h-index
- 159LetPub ·
- h-index
- 248OpenAlex ·
- i10-index
- 12,695OpenAlex ·
- 2-year mean citedness
- 1.29OpenAlex ·
- Self-citation rate
- 2.8%LetPub ·
- Share of gold OA articles
- 41.17%LetPub ·
Volume
- Articles per year
- 229LetPub ·
Articles by year OpenAlex count · 37,125 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,202 | 120 | 132 |
| 2025 | 906 | 690 | 1,714 |
| 2024 | 1,397 | 957 | 2,690 |
| 2023 | 1,195 | 895 | 5,000 |
| 2022 | 1,269 | 968 | 5,819 |
| 2021 | 1,228 | 210 | 7,643 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
105 daysMedian, submission to acceptance · P25–P75 60 days – 162 days
- Acceptance to online
- median 8 days (98 articles)
- Submission to online
- median 121 days
- Sample
- 98 articles with submission and acceptance dates (557 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 33.33%LetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,020 / EUR 3,760 / GBP 3,220 / JPY 498,600 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Elsevier Ireland Ltd
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1970
- ISSN
- 0021-9150
- Electronic ISSN
- 1879-1484
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Atherosclerosis
What CAS zone is Atherosclerosis in?
In the 2025 upgraded edition of the CAS Journal Ranking, Atherosclerosis is in Zone 2 of Medicine, and in Zone 2 of the minor category Peripheral Vascular Disease / Cardiac & Cardiovascular Systems; it is a Top journal. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Atherosclerosis?
The latest impact factor listed by LetPub is 6.93; CiteScore 10.2, h-index 248.
How long does peer review take at Atherosclerosis?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 105 days (interquartile range 60–162 days); authors report an average review time of about 3 months. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Atherosclerosis?
According to LetPub and DOAJ records, Atherosclerosis is indexed in SCIE and Scopus.
Is Atherosclerosis open access, and what is the APC?
Atherosclerosis is a hybrid journal. For open-access publication: APC about USD 4,020.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .